Journals / Turkish Journal of Obstetrics and Gynecology / 2019 / Cilt: 16 - Sayı: 1

Palliative pelvic exenteration using iliofemoral bypass with synthetic grafts for advanced cervical carcinoma

İleri evre serviks kanseri için yapılan palyatif pelvik egzenterasyonda sentetik greftli ilyofemoral bypass kullanılması

Pages
80–83
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

They must be considered in the basis of each patient, and the benefits and risks must be discussed thoroughly in a realistic perspective with the patient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Recurrent cervical cancer can cause severe morbidity.
📊
Key Findings & Data:The same is true for exenteration for palliative intent, so the patient selection for either curative or palliative intent must be considered on a patient-by-patient basis.Materials and Methods: A 35-year-old patient who had undergone primary chemo-radiotherapy for advanced cervical cancer presented with intractable pain on the swollen left leg and pelvis 8 months later.
💡
Conclusion & Impact:They must be considered in the basis of each patient, and the benefits and risks must be discussed thoroughly in a realistic perspective with the patient.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Recurrent cervical cancer can cause severe morbidity. Despite the severe morbidity after surgery, pelvic exenteration is still used today for mainly curative intent. This intention is neither based on randomized controlled trials (RCTs) nor high quality non-RCTs with adequate patient numbers comparing medical management with surgery. The same is true for exenteration for palliative intent, so the patient selection for either curative or palliative intent must be considered on a patient-by-patient basis.Materials and Methods: A 35-year-old patient who had undergone primary chemo-radiotherapy for advanced cervical cancer presented with intractable pain on the swollen left leg and pelvis 8 months later. Left lower extremity Doppler ultrasound revealed echogenic thrombus in the external iliac, femoral, and popliteal veins, consistent with acute deep vein thrombus. She underwent total exenteration, end colostomy, ileal urinary conduit, pelvic lymphadenectomy, paraortic lymph node sampling, and ilio-femoral arterial and venous bypass.Results: The procedure relieved her pain, the leg diameter dramatically decreased from 75 cm to 44 cm, and circulation of the leg was reestablished. The procedure deferred leg amputation for about five months.Conclusion: To the best of our knowledge, this is the first report of a palliative pelvic exenteration for cervical cancer with combined iliofemoral arterial and venous bypasses. These procedures, with high morbidity and mortality, are also more controversial when undertaken for just palliation of symptoms. They must be considered in the basis of each patient, and the benefits and risks must be discussed thoroughly in a realistic perspective with the patient.

Özet

Amaç: Nüks serviks kanseri ciddi morbiditeye neden olabilir. Cerrahi sonrası yüksek morbiditeye rağmen, pelvik egzenterasyon günümüzde temel olarak küratif amaçlı kullanılır. Bu yaklaşım, medikal tedavi ve cerrahiyi karşılaştıran randomize kontrollü çalışmalar (RCT) ya da yüksek kaliteli yeterli sayıda hastayı içeren RCT dışı çalışma temelli değildir. Aynı durum palyasyon amaçlı yapılan egzenterasyon için geçerlidir. Bu nedenle palyatif ya da küratif amaçlı yapılan egzenterasyonun hasta seçimi hasta bazlı olmalıdır.Gereç ve Yöntemler: İleri evre serviks kanseri için daha önce primer kemo-radyoterapi almış olan 35 yaşındaki hasta, tedaviden 8 ay sonra sol bacakta şişlik ve anti enflamatuvar ilaçlarla dinmeyen ağrı şikayeti ile başvurdu. Sol alt ekstremite Doppler incelemesinde akut derin ven trombozu ile uyumlu; eksternal ilyak, femoral ve popliteal venlerde ekojenik trombüs saptandı. Hastaya total pelvik egzenterasyon, uç kolostomi, ileal üriner konduit, pelvikparaaortik lenfadenektomi ve ilio-femoral arteriyel ve venöz bypass yapıldı.Bulgular: Operasyon hastanın ağrısını dindirdi, bacak çapı 75 cm’den 44 cm’ye dramatik olarak geriledi ve bacaktaki dolaşım yeniden sağlandı. Bu operasyon, bacak ampütasyonunu 5 ay öteledi.Sonuç: Bildiğimiz kadarı ile bu olgu sunumu, kombine ilio-femoral arteryel ve venöz bypass içeren ilk palyatif egzenterasyon sunumudur. Bu tip bir cerrahi işlemin yüksek morbidite ve mortalitesi vardır. Özellikle sadece palyasyon amaçlı kullanımı tartışmalıdır ve hasta bazlı tartışılmalıdır. İşlemin risk ve faydaları gerçekçi bir perspektifte hasta ile paylaşılmalıdır.

🔖

Cite This Article

ERDEMOĞLU, E., YALÇIN, Y., TATAR, B. (2022). Palliative pelvic exenteration using iliofemoral bypass with synthetic grafts for advanced cervical carcinoma. Turkish Journal of Obstetrics and Gynecology, Cilt: 16 - Sayı: 1, 80–83. https://ajindex.com/articles/613016

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians 2015;65:87-108
  2. Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. International journal of radiation oncology, biology, physics 2004;60:249-57
  3. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1948;1:177-83
  4. Marnitz S, Kohler C, Muller M, Behrens K, Hasenbein K, Schneider A. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecologic oncology 2006;103:1023-30
  5. Berek JS, Howe C, Lagasse LD, Hacker NF. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecologic oncology 2005;99:153-9
  6. Lambrou NC, Pearson JM, Averette HE. Pelvic exenteration of gynecologic malignancy: indications, and technical and reconstructive considerations. Surgical oncology clinics of North America 2005;14:289-300
  7. Guimaraes GC, Baiocchi G, Ferreira FO, Kumagai LY, Fallopa CC, Aguiar S, et al. Palliative pelvic exenteration for patients with gynecological malignancies. Archives of gynecology and obstetrics 2011;283:1107-12
  8. Deckers PJ, Olsson C, Williams LA, Mozden PJ. Pelvic exenteration as palliation of malignant disease. American journal of surgery 1976;131:509-15
  9. Finlayson CA, Eisenberg BL. Palliative pelvic exenteration: patient selection and results. Oncology (Williston Park) 1996;10:479-84; discussion 84-6, 90, 93
  10. Hope JM, Pothuri B. The role of palliative surgery in gynecologic cancer cases. The oncologist 2013;18:73-9
  11. Ang C, Bryant A, Barton DP, Pomel C, Naik R. Exenterative surgery for recurrent gynecological malignancies. The Cochrane database of systematic reviews 2014;2:CD010449
  12. Hockel M. Laterally extended endopelvic resection. Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall. Gynecologic oncology 2003;91:369-77
  13. Caceres A, Mourton SM, Bochner BH, Gerst SR, Liu L, Alektiar KM, et al. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society 200